Prof. Qing Wang | Southern Medical University | China
Professor Dennis Qing Wang is a distinguished neurologist and neuroscientist recognized for his pioneering research in neurodegenerative diseases, brain imaging, and translational neuroscience. With more than two decades of clinical and academic experience, he has made outstanding contributions to understanding the mechanisms of Alzheimer’s disease, Parkinson’s disease, and cognitive decline. Professor Wang holds an MD from the National Defense Medical Center, an MSc in Clinical Neurology from National Yang-Ming University, and a PhD in Neuroscience from the University of Tokyo, Japan. His multidisciplinary work bridges advanced neuroimaging and molecular neuroscience, fostering early diagnostics and therapeutic innovations that bridge laboratory research and patient care. He has authored 66 peer-reviewed scientific papers, which have collectively received 3,423 citations across 3,040 documents, demonstrating the global impact of his research. With an h-index of 30, his scholarship reflects both depth and sustained influence in the neuroscience community. As Professor of Neurology at Changhua Christian Hospital, he leads research initiatives in neurogenetics, cognitive neuroscience, and neurodegeneration, supervising emerging scientists and clinicians in the field. He has been invited to deliver lectures at leading international conferences and actively contributes to global collaborations in clinical neuroscience.
Featured Publications
Wang, D. Q., et al. (2025). Development and validation of a polysomnography-based nomogram for predicting amnestic mild cognitive impairment in middle-aged and elderly people. Sleep Medicine.
Wang, D. Q., et al. (2025). Vascular depression: A comprehensive exploration of the definition, mechanisms, and clinical challenges.
Wang, D. Q., et al. (2025). Cellular fibronectin exacerbates α-synuclein aggregation via integrin α4β1-mediated PARP1 and SCD elevation. Neurotherapeutics.
Wang, D. Q., et al. (2025). Fibrinogen exacerbates α-synuclein aggregation and mitochondrial dysfunction via α5β3 integrin in Parkinson’s disease.
Wang, D. Q., et al. (2024). Lee Silverman Voice Treatment for dysarthria in patients with Parkinson’s disease: A systematic review and meta-analysis.